Johnson And Johnson's Revenue in the fiscal year 2025 $ 94,193.00 millions
Johnson And Johnson's Revenue in the fiscal year 2024 $ 88,821.00 millions
Johnson And Johnson's Revenue in the fiscal year 2023 $ 85,159.00 millions
Johnson And Johnson's Revenue in the fiscal year 2022 $ 94,943.00 millions
Johnson And Johnson's Revenue in the fiscal year 2021 $ 93,775.00 millions
JNJ Revenue third quarter 2026 Y/Y Growth Comment
Johnson and Johnson achieved in the third quarter 2026, above Company average Revenue improvement of 5.86% year on year, to $ 25,399.00 millions.
Looking into third quarter 2026 results within Major Pharmaceutical Preparations industry 115 other companies have achieved higher Revenue growth. While Johnson And Johnson' s Revenue increase of 5.86% ranks overall at the positon no. 2461 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Johnson And Johnson's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
14.98 %
0.99 %
-16.37 %
JNJ's III. Quarter Q/Q Revenue Comment
Johnson and Johnson achieved in the III. Quarter 2026 below company average Revenue growth of 0.35% quarter on quarter, to $ 25,399.00 millions.
Within Major Pharmaceutical Preparations industry 82 other companies have achieved higher Revenue quarter on quarter growth. While Johnson And Johnson's Revenue growth quarter on quarter, overall rank is 1746.
Johnson and Johnson achieved in the III. Quarter 2026 below company average Revenue growth of 0.35% quarter on quarter, to $ 25,399.00 millions.
Within Major Pharmaceutical Preparations industry 82 other companies have achieved higher Revenue quarter on quarter growth. While Johnson And Johnson's Revenue growth quarter on quarter, overall rank is 1746.
Johnson And Johnson's 12 Months Revenue Growth Year on Year
Assuming the Johnson And Johnson's fiscal year would have ended in Sep 27 2026, Johnson And Johnson would have reprted above average annual Revenue improvement of 7.8% year on year, of $ 99,335 millions. This marks a slow-down of the companys growth trends and from the 8.06% growth in Jun 28 2026.
In the Healthcare sector 311 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2068, from total ranking in previous quarter at 2488.
Assuming the Johnson And Johnson's fiscal year would have ended in Sep 27 2026, Johnson And Johnson would have reprted above average annual Revenue improvement of 7.8% year on year, of $ 99,335 millions. This marks a slow-down of the companys growth trends and from the 8.06% growth in Jun 28 2026.
In the Healthcare sector 311 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2068, from total ranking in previous quarter at 2488.
About Johnson And Johnson Revenue Growth Rates (JNJ), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
10.17%